Pacific Biosciences of California, Inc. Analysis
| Analyst Ratings |
|
Average Target Price
|
12.14
|
|
Average Rating
|
3.86
|
|
# Strong Buys
|
2
|
|
# Buys
|
2
|
|
# Holds
|
3
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2022-09-30
|
-0.33
|
-0.34
|
-0.01
|
-3.03%
|
|
2022-06-30
|
-0.32
|
-0.32
|
0.00
|
0.00%
|
|
2022-03-31
|
-0.31
|
-0.37
|
-0.06
|
-19.35%
|
|
2021-12-31
|
-0.28
|
-0.31
|
-0.03
|
-10.71%
|
|
2021-09-30
|
-0.22
|
0.08
|
0.30
|
136.36%
|
|
2021-06-30
|
-0.21
|
-0.21
|
0.00
|
0.00%
|
|
2021-03-31
|
-0.46
|
-0.45
|
0.01
|
2.17%
|
|
2020-12-31
|
0.32
|
0.37
|
0.05
|
15.63%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
-1.03
|
|
2021-12-31
|
-0.89
|
|
2020-12-31
|
0.09
|
|
2019-12-31
|
-0.66
|
|
2018-12-31
|
-0.77
|
|
2017-12-31
|
-0.89
|
|
2016-12-31
|
-0.84
|
|
2015-12-31
|
-0.43
|
|
2014-12-31
|
-0.94
|
|
2013-12-31
|
-1.24
|
|
2012-12-31
|
-1.70
|
|
2011-12-31
|
-1.95
|
|
2010-12-31
|
-40.67
|